Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Solo logo — Solo is a service for personalized anticancer therapy select...

Solo

Solo is a service for personalized anticancer therapy selection.

Founded 2016 Pre-Seed Total: $5.00M Biotechnology, Health Care +1

General Information

Company Name Solo
Founded Year 2016
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Solo. To contact Solo, visit solo.atlas.ru.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Solo compare?

A PDF of Solo and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Solo soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Solo

Solo is a biotechnology startup founded in 2016 that specializes in personalized anticancer therapy selection. The company has gained attention in the Health Care and Pharmaceutical industries and has already secured a substantial RUB5.00M Pre-Seed Round investment from Primer Capital on 30 September 2016. This significant investment highlights the market's confidence in Solo's innovative approach to cancer therapy. With its unique service, Solo is poised to make a meaningful impact in the field of personalized medicine, offering valuable solutions for cancer patients.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round RUB5.00M 1
Primer Capital
Primer Capital
30 Sep 2016

Solo Alternatives & Competitors

View All Alternatives
Solo vs
Voximetry
Voximetry United States

Personalized Treatment Planning for Radiopharmaceutical Therapy

Grant
28 employees
Biotechnology, Health Care
Solo vs
Encapsulate
Encapsulate United States

Precision Diagnostics for Personalized Cancer Therapy

Non Equity Assistance
8 employees
Health Care, Medical Devices
Solo vs
Aummune
Aummune Israel

WE ARE ALL UNIQUE SO IS AUMMUNE. The future of personalized therapy for cancer

18 employees
Biotechnology, Design
View all alternatives

FAQ About Solo

Solo is a service for personalized anticancer therapy selection.
Solo was founded in 2016.
Solo operates in Biotechnology, Health Care and Pharmaceutical.
Solo has completed 1 funding round, raising a total of $5.00M. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Solo include Voximetry, Encapsulate, Aummune, AVROBIO, HDT Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Solo and Voximetry are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Solo, https://bouncewatch.com/company/solo-1, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes